Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 9.07
(3.66%)
CNY 9.07
(3.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 816.76 Million | 764.54 Million | 569.69 Million | 409.24 Million | 307.91 Million | 243.88 Million |
| Cost of Revenue | 367.15 Million | 370.79 Million | 257.57 Million | 178.29 Million | 148.47 Million | 134.98 Million |
| Gross Profit | 449.61 Million | 393.75 Million | 312.12 Million | 230.95 Million | 159.44 Million | 108.9 Million |
| Operating Expenses | 158.79 Million | 179.66 Million | 152.62 Million | 110.32 Million | 99.75 Million | 78.38 Million |
| Selling, General and Administrative Expenses | 70.24 Million | 60.53 Million | 40.91 Million | 33.93 Million | 33.24 Million | 23.56 Million |
| Research and Development Expenses | 78.05 Million | 67.07 Million | 68.82 Million | 50.77 Million | 47.74 Million | 34.37 Million |
| Other Expenses | -5.25 Million | 52.05 Million | 42.88 Million | 25.61 Million | 18.75 Million | 1.58 Million |
| Cost and Expenses | 525.94 Million | 550.45 Million | 410.2 Million | 288.61 Million | 248.22 Million | 213.37 Million |
| Operating Income | 290.82 Million | 257.71 Million | 160.15 Million | 96.61 Million | 61.1 Million | 47.24 Million |
| Interest Expense | 8.27 Million | 6.1 Million | 1.46 Million | 1.38 Million | 2.51 Million | 3.06 Million |
| Income Tax Expense | 36.86 Million | 20.48 Million | 13.46 Million | 8.66 Million | 4.21 Million | 3.45 Million |
| Earnings before Tax | 290.76 Million | 255.85 Million | 159.39 Million | 95.49 Million | 60.6 Million | 47.32 Million |
| Net Income | 253.9 Million | 235.37 Million | 145.93 Million | 86.83 Million | 56.38 Million | 43.86 Million |
| Earnings Per Share Basic | 0.43 | 0.42 | 0.26 | 0.17 | 0.11 | 0.08 |
| Earnings Per Share Diluted | 0.43 | 0.42 | 0.26 | 0.17 | 0.11 | 0.08 |
| Weighted Average Shares Outstanding | 593.06 Million | 562.61 Million | 560.82 Million | 523.68 Million | 526.84 Million | 526.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 593.06 Million | 562.61 Million | 560.82 Million | 523.68 Million | 526.84 Million | 534.94 Million |
| Gross Margin | 0.55 | 0.52 | 0.55 | 0.56 | 0.52 | 0.45 |
| EBIT Margin | 0.42 | 0.39 | 0.33 | 0.31 | 0.30 | 0.29 |
| Profit Margin | 0.31 | 0.31 | 0.26 | 0.21 | 0.18 | 0.18 |
| EBITDA | 339.62 Million | 296.88 Million | 191.29 Million | 122.52 Million | 86.04 Million | 71.23 Million |
| Earnings Before Tax Margin | 0.36 | 0.34 | 0.28 | 0.24 | 0.20 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 196.12 Million | 188.83 Million | 299.05 Million | 810.2 Million | 142.95 Million | 202.94 Million |
| Cost of Revenue | 92.35 Million | 75.6 Million | 125.52 Million | 367.15 Million | 82.86 Million | 87.43 Million |
| Gross Profit | 103.77 Million | 113.22 Million | 173.53 Million | 443.05 Million | 60.09 Million | 115.5 Million |
| Operating Expenses | 51.43 Million | 48.26 Million | 53.37 Million | 187.55 Million | 26.66 Million | 46.15 Million |
| Selling, General and Administrative Expenses | 27.83 Million | 30.94 Million | 30.12 Million | - | 20.23 Million | 52.04 Million |
| Research and Development Expenses | 23.6 Million | 15.76 Million | 23.25 Million | - | 3.17 Million | 25.78 Million |
| Other Expenses | - | -1.56 Million | -346.99 Thousand | 185.67 Million | 23.4 Million | 426.77 Thousand |
| Cost and Expenses | 143.78 Million | 123.87 Million | 178.9 Million | 569.21 Million | 111.25 Million | 133.58 Million |
| Operating Income | 52.33 Million | 64.95 Million | 120.15 Million | 290.82 Million | 34.96 Million | 72.2 Million |
| Interest Expense | 1.97 Million | 1.92 Million | 1.73 Million | 7.99 Million | 1.96 Million | 1.94 Million |
| Income Tax Expense | 4.55 Million | 10.2 Million | 17.52 Million | 36.86 Million | 5.91 Million | 7.48 Million |
| Earnings before Tax | 53.71 Million | 77.55 Million | 130.01 Million | 290.76 Million | 34.47 Million | 72.63 Million |
| Net Income | 49.15 Million | 67.35 Million | 112.48 Million | 253.9 Million | 28.56 Million | 65.14 Million |
| Earnings Per Share Basic | 0.06 | 0.08 | 0.19 | - | 0.05 | 0.11 |
| Earnings Per Share Diluted | 0.06 | 0.08 | 0.19 | - | 0.05 | 0.11 |
| Weighted Average Shares Outstanding | 830.29 Million | 830.29 Million | 593.06 Million | 593.06 Million | 593.06 Million | 593.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 830.29 Million | 830.29 Million | 593.06 Million | 593.06 Million | 593.06 Million | 593.06 Million |
| Gross Margin | 0.53 | 0.60 | 0.58 | 0.55 | 0.42 | 0.57 |
| EBIT Margin | 0.28 | 0.43 | 0.47 | - | 0.27 | 0.39 |
| Profit Margin | 0.25 | 0.36 | 0.38 | 0.31 | 0.20 | 0.32 |
| EBITDA | 55.68 Million | 80.54 Million | 139.48 Million | - | 38.56 Million | 78.25 Million |
| Earnings Before Tax Margin | 0.27 | 0.34 | 0.40 | 0.36 | 0.24 | 0.36 |
HR-UN
BMXC
GIGA
000807
ALDVF
601878